Global IVD Raw Materials Industry Insights: Key Trends and Growth Estimates

Uncover key drivers, emerging technologies, and competitive movements shaping the ivd raw materials market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the IVD Raw Materials Market be in 2030 compared with 2026?

The ivd raw materials market has observed substantial growth in recent times. Its value is anticipated to climb from $27.47 billion in 2025 to $30.16 billion by 2026, progressing at a compound annual growth rate (CAGR) of 9.8%. The historical expansion of this market can be linked to factors such as increased volumes in clinical diagnostic testing, the growing adoption of immunoassays, the widening reach of molecular diagnostics, an escalating demand for early disease detection, and the well-established utilization of enzymes and antibodies within ivd kits.

The ivd raw materials market size is anticipated to experience significant growth in the upcoming years. It is projected to expand to $43.76 billion by 2030, with a compound annual growth rate (CAGR) of 9.8%. This growth throughout the forecast period stems from factors such as the increasing prevalence of chronic and infectious diseases, greater investment in precision diagnostics, the expansion of point-of-care testing, broadening biopharmaceutical research and development activities, and a rising need for customized ivd raw materials. Significant trends during the forecast period involve an escalating demand for high-purity diagnostic reagents, the increasing adoption of recombinant antibodies and proteins, a wider application of molecular diagnostics raw materials, a heightened focus on quality and batch consistency, and the diversification of supply chains for critical ivd inputs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24270&type=smp

What Drivers Are Guiding Growth Patterns In The IVD Raw Materials Market?

The rising occurrence of infectious diseases is projected to drive expansion within the IVD raw materials market in the foreseeable future. These diseases refer to sicknesses caused by detrimental microorganisms capable of transmission between individuals or organisms. The growing incidence of infectious diseases stems from swift urbanization, which fosters their spread by heightening population density and putting pressure on sanitation and healthcare systems. IVD raw materials are vital in confronting infectious diseases, as they facilitate the creation of precise diagnostic tools essential for prompt identification and efficient management of these conditions. For example, data from March 2024, provided by the US-based government agency, the Centers for Disease Control and Prevention, showed a rise in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. Consequently, the escalating occurrence of infectious diseases is fueling the expansion of the IVD raw materials market.

How Is The IVD Raw Materials Market Divided Into Segments?

The ivd raw materials market covered in this report is segmented –

1) By Product: Antibodies, Antigens, Enzymes, Proteins, Biological Buffers

2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunochemistry

3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations

Subsegments:

1) By Antibodies: Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies

2) By Antigens: Recombinant Antigens, Native Antigens, Synthetic Antigens

3) By Enzymes: Polymerases, Reverse Transcriptases, Oxidases

4) By Proteins: Carrier Proteins, Blocking Proteins, Recombinant Proteins

5) By Biological Buffers: Tris Buffers, HEPES Buffers, Phosphate Buffers

What Trends Are Reshaping The Dynamics Of The IVD Raw Materials Market?

Major companies operating in the IVD raw materials market are concentrating on developing advanced solutions, such as IVD manufacturing facilities, to bolster regional diagnostic capabilities and support healthcare self-sufficiency. An IVD (in vitro diagnostic) manufacturing facility is a specialized site where devices and equipment used for diagnosing diseases and conditions through laboratory testing of samples outside the human body are designed, produced, and rigorously tested for quality and compliance. For instance, in January 2024, Colexa Biosensor Limited, a Nigeria-based health technology company, joined forces with Codix Pharma Limited, a Nigeria-based pharmaceutical manufacturing company, to inaugurate Sub-Saharan Africa’s first in vitro diagnostics (IVD) manufacturing facility in Lagos. This facility, which manufactures the onpoint blood glucose meter and strips, marks a significant achievement in Africa’s healthcare industry, aimed at addressing the increasing diabetes prevalence and improving diagnostic accessibility. The facility has an annual production capacity of 3.6 million packs, with the potential for expansion to 10.8 million packs, initially prioritizing the demands of West Africa.

Which Major Industry Participants Are Leading The IVD Raw Materials Market Growth?

Major companies operating in the ivd raw materials market are Merck KGaA, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., LGC Limited, Neogen Corporation, MP Biomedicals, CUSABIO Technology, Fujirebio, Fapon Biotech, ABclonal Technology, Creative Diagnostics, AIVD Biotech Inc., OPERON, Beijing Diagreat Biotechnology Co. Ltd., Biosynth, Aalto Bio Reagents, Angstrom Biotech, Eximio Biotech, Glentham Life Sciences Limited, OYC Americas Inc., NOVA Biologics Inc., Sino Biological Inc., ACROBiosystems, ProSpec-Tany TechnoGene Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/ivd-raw-materials-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The IVD Raw Materials Market?

North America was the largest region in the IVD raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ivd raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized IVD Raw Materials Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24270&type=smp

Browse Through More Reports Similar to the Global IVD Raw Materials Market 2026, By The Business Research Company

Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

Medical Engineered Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-engineered-materials-global-market-report

International Wholesale Voice Carrier Market Report 2026

https://www.thebusinessresearchcompany.com/report/international-wholesale-voice-carrier-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795